• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRI™ Website
      • ISPRI Downselect™
      • ISPRI Quantify™
      • ISPRI Analyze™
      • ISPRI Evaluate™
      • ISPRI-HCP™
      • ISPRI Design™
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAX™
      • EpiCC™
      • Ancer®
      • PreVAX™
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)

EpiVax Announces Participation in International Consortium for Development of Next-Generation Influenza Vaccines (INDIGO)

by Elena Iemma | Feb 17, 2021 | News

PROVIDENCE, RI, February 17, 2021 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) today announces its participation in the INDIGO consortium – a partnership of public and private research and development organizations from the EU, India, and United States (funded by the...
Options X for the Control of Influenza August 28th-September 1st, 2019

Options X for the Control of Influenza August 28th-September 1st, 2019

by Annie De Groot | Jun 28, 2019 | Events

The 10th Edition of Options for the Control of Influenza Wednesday, August 28th – Sunday, September 1st Suntec Convention and Exhibition Centre 1 Raffles Blvd Suntec City, Singapore 039593 Swan Tan, Graduate Research Assistant at iCubed (URI), is the recipient...
Influenza Vaccines for the World Conference April 2nd-4th, 2019

Influenza Vaccines for the World Conference April 2nd-4th, 2019

by Annie De Groot | Mar 5, 2019 | Events

7th International Conference: Influenza Vaccines for the World Tuesday, April 2nd – Thursday, April 4th Royal College of Physicians of Edinburgh Edinburgh, Scotland, United Kingdom Join our Scientific Director in Vaccine Research, Lenny Moise, at IVW 2019, as he...

Recent Posts

  • The Platinum Vaccine & Change is Good!
  • EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
  • Smarter Tools, Safer Therapies: Supporting the FDA’s Roadmap with in silico Immunogenicity Assessment
  • The Amsterdam Immunogenicity & Tolerance Seminar: 2025
  • The Westin Immunogenicity Seminar

Recent Comments

No comments to show.

Join our newsletter

Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CMO, Dr. Annie De Groot.

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.AcceptDecline